KK
VERA icon

KLP Kapitalforvaltning’s Vera Therapeutics VERA Stock Holding History

KLP Kapitalforvaltning’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Buy
9,700
+1,200
+14% +$44.7K ﹤0.01% 1587
2026
Q1 		$342K Hold
8,500
– – ﹤0.01% 1602
2025
Q4 		$430K Hold
8,500
– – ﹤0.01% 1485
2025
Q3 		$247K Hold
8,500
– – ﹤0.01% 1734
2025
Q2 		$200K Sell
8,500
-1,700
-17% -$38.2K ﹤0.01% 1787
2025
Q1 		$245K Hold
10,200
– – ﹤0.01% 1659
2024
Q4 		$431K Buy
+10,200
New +$452K ﹤0.01% 1462

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KLP Kapitalforvaltning's VERA Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Vera Therapeutics (VERA) stake by 14% in Q2 2026, buying an estimated $44.7K and bringing the position to 9,700 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

KLP Kapitalforvaltning first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. The position peaked at $431K in Q4 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • KLP Kapitalforvaltning held 9,700 shares of Vera Therapeutics worth $416K as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,200 Vera Therapeutics shares in Q2 2026, an estimated $44.7K.
  • Vera Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1587 holding.
  • KLP Kapitalforvaltning first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Vera Therapeutics position peaked at $431K in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.